Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.

Multiple copies of SEQ13 displayed on the surface of this particulate antigen promote the induction of a potent anti-HBs antibody response in mice, rabbits and cynomolgus monkeys. Sera and purified ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Regular Abstracts Accepted as Poster Presentations Presentation Title: Soluble Immune Biomarker Profiling of Chronic Hepatitis B Subjects Treated with Imdusiran in Combination with Pegylated ...

单独分析HBcAb意义不大，可与其他HBV血清标志物相互补充分析，也就是我们常说的乙肝“两对半”。如HBsAg、HBeAg和HBcAb同时呈阳性，表示乙肝 大三阳 ；HBsAg、HBeAb和HBcAb同时呈阳性，表示乙肝小三阳。

A 12-month or longer course of interferon-alfa treatment or re-treatment achieves sustained biochemical responses in 20% to 25% of patients, with eventual hepatitis B surface antigen (HBsAg ...

Vir Biotechnology, Inc. (NASDAQ:VIR) today announced it will present new data from the Phase 2 SOLSTICE clinical trial ...

导读显性乙型肝炎病毒即慢性乙型肝炎病毒（Chronic Hepatitis B,CHB）感染的特征是血清中检测到乙肝表面抗原（hepatitis B surface antigen, ...

Interim results from the phase 2b B-Clear showed that bepirovirsen reduced levels of hepatitis B surface antigen (HBsAg) and HBV DNA after 24 weeks' treatment to below the lower limit of detection ...

In the Phase Ib/IIa trial, VTP-300 was observed to induce meaningful, sustained reductions of hepatitis B surface antigen (HBsAg) in patients with CHB. VTP-300 is a vaccine comprised of chimpanzee ...

Investigational immunotherapy, VTP-300, is being evaluated as part of a potential functional cure regimen for chronic ...